$1.52
0.021.33%
Pre-Market: 7:25 PM EDT
Comments
Loading...
AN2 Therapeutics Insider Trading Activity | NASDAQ:ANTX | Benzinga
Track the latest AN2 Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for AN2 Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are AN2 Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 7, 2025, Stephen David Prior, the company's CHIEF STRATEGY OFFICER sold 2.03K shares for $1.34 each.
- On January 7, 2025, Lucy Day, the company's CHIEF FINANCIAL OFFICER sold 2.96K shares for $1.34 each.
- On January 7, 2025, Sanjay Chanda, the company's CHIEF DEVELOPMENT OFFICER sold 2.96K shares for $1.34 each.
Ownership Statistics for AN2 Therapeutics Inc
Shares Outstanding
29.879M
Insider Shares Owned
913.471K
Insider Percentage Owned
3.06%
Institutional Shares Held
1.397M
Institutional Percentage Held
4.67%
| Jan 07, 2025 | Lucy Day | CHIEF FINANCIAL OFFICER | -2.96K | $1.34 | -$3.97K | SELL | -8.30% | 32.67K | Jan 03 | View |
| Jan 07, 2025 | Sanjay Chanda | CHIEF DEVELOPMENT OFFICER | -2.96K | $1.34 | -$3.97K | SELL | -9.02% | 29.82K | Jan 03 | View |
| Jan 07, 2025 | Stephen David Prior | CHIEF STRATEGY OFFICER | -2.03K | $1.34 | -$2.72K | SELL | -5.74% | 33.31K | Jan 03 | View |
| Jan 07, 2025 | Joshua M Eizen | SEE REMARKS | -9.66K | $1.34 | -$12.96K | SELL | -7.65% | 116.67K | Jan 03 | View |
| Dec 10, 2024 | Robin Shane Readnour | — | 60.00K | $1.45 | $86.71K | BUY | 10.13% | 652.57K | Dec 06 - Dec 10 | View |
| Nov 27, 2024 | Robin Shane Readnour | — | 75.00K | $1.41 | $105.69K | BUY | 13.70% | 622.57K | Nov 26 - Nov 27 | View |
| Nov 27, 2024 | Joseph S Zakrzewski | — | 2.00K | $1.40 | $2.80K | BUY | 0.38% | 531.08K | Nov 27 | View |
| Nov 21, 2024 | Robin Shane Readnour | — | 200.00K | $1.07 | $213.13K | BUY | 63.53% | 514.79K | Nov 19 - Nov 20 | View |
| Nov 20, 2024 | Joseph S Zakrzewski | — | 25.00K | $1.00 | $25.05K | BUY | 4.96% | 529.08K | Nov 18 - Nov 19 | View |
| Nov 18, 2024 | Eric Easom | CHIEF EXECUTIVE OFFICER | 50.00K | $1.00 | $49.97K | BUY | 4.49% | 1.16M | Nov 18 | View |
| Aug 14, 2024 | Braden Michael Leonard | — | 1.50M | $1.04 | $1.56M | BUY | 35.30% | 5.75M | Aug 14 | View |
| Aug 13, 2024 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | -3.53M | $1.08 | -$3.81M | SELL | -92.14% | 300.85K | Aug 09 | View |
| Jan 19, 2024 | Joseph Zakrzewski | — | -100.00K | $19.11 | -$1.91M | SELL | -16.55% | 504.08K | Jan 18 | View |
| Jan 18, 2024 | Kabeer Aziz | — | -100.00K | $19.65 | -$1.97M | SELL | -20.94% | 377.54K | Jan 16 | View |
| Jan 18, 2024 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -100.00K | $19.65 | -$1.97M | SELL | -20.94% | 377.54K | Jan 16 | View |
| Jan 17, 2024 | Robin Shane Readnour | DIRECTOR | -1.43K | $21.91 | -$31.23K | SELL | -0.29% | 485.07K | Jan 12 | View |
| Jan 12, 2024 | Robin Shane Readnour | DIRECTOR | -3.67K | $21.93 | -$80.44K | SELL | -0.75% | 485.79K | Jan 10 | View |
| Jan 11, 2024 | Kevin Michael Krause | CHIEF STRATEGY OFFICER | 0.00 | $12.36 | -$115.35K | SELL-OPTIONS | 0.00% | 1.91K | Jan 09 | View |
| Jan 04, 2024 | Kevin Michael Krause | CHIEF STRATEGY OFFICER | 0.00 | $10.27 | -$50.88K | SELL-OPTIONS | 0.00% | 1.91K | Jan 02 | View |
| Jan 04, 2024 | Eric Easom | CHIEF EXECUTIVE OFFICER | -2.78K | $20.09 | -$55.80K | SELL | -2.72% | 99.19K | Jan 02 | View |
| Nov 16, 2023 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -1.81K | $16.15 | -$29.22K | SELL | -0.46% | 393.45K | Nov 14 | View |
| Nov 16, 2023 | Kabeer Aziz | — | -1.81K | $16.15 | -$29.22K | SELL | -0.46% | 393.45K | Nov 14 | View |
| Oct 03, 2023 | Kabeer Aziz | — | -104.77K | $16.27 | -$1.70M | SELL | -21.02% | 393.74K | Sep 29 - Oct 02 | View |
| Oct 03, 2023 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -104.77K | $16.27 | -$1.70M | SELL | -21.02% | 393.74K | Sep 29 - Oct 02 | View |
| Sep 29, 2023 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -9.36K | $16.11 | -$150.71K | SELL | -2.23% | 410.40K | Sep 27 - Sep 28 | View |
| Sep 29, 2023 | Kabeer Aziz | — | -9.36K | $16.11 | -$150.71K | SELL | -2.23% | 410.40K | Sep 27 - Sep 28 | View |
| Sep 15, 2023 | Kabeer Aziz | — | -400.00 | $16.00 | -$6.40K | SELL | -0.10% | 411.89K | Sep 13 | View |
| Sep 15, 2023 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -400.00 | $16.00 | -$6.40K | SELL | -0.10% | 411.89K | Sep 13 | View |
| Sep 08, 2023 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -7.14K | $16.03 | -$114.48K | SELL | -1.70% | 411.96K | Sep 06 - Sep 07 | View |
| Sep 08, 2023 | Kabeer Aziz | — | -7.14K | $16.03 | -$114.48K | SELL | -1.70% | 411.96K | Sep 06 - Sep 07 | View |
| Aug 25, 2023 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC | — | -400.00 | $16.00 | -$6.40K | SELL | -0.10% | 413.09K | Aug 23 | View |
| Aug 25, 2023 | Kabeer Aziz | — | -400.00 | $16.00 | -$6.40K | SELL | -0.10% | 413.09K | Aug 23 | View |
| Aug 22, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | 1.78M | $9.00 | $16.00M | BUY | 47.11% | 5.55M | Aug 18 | View |
| May 15, 2023 | Eric Easom | CHIEF EXECUTIVE OFFICER | 10.00K | $5.38 | $53.77K | BUY | 0.91% | 1.11M | May 15 | View |
| Nov 14, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -4.44K | $15.32 | -$67.97K | SELL | -47.48% | 4.91K | Nov 10 - Nov 14 | View |
| Nov 09, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -17.17K | $15.60 | -$267.79K | SELL | -77.77% | 4.91K | Nov 08 - Nov 09 | View |
| Nov 07, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -35.20K | $15.86 | -$558.27K | SELL | -87.76% | 4.91K | Nov 03 - Nov 07 | View |
| Nov 02, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -4.23K | $15.27 | -$64.63K | SELL | -46.31% | 4.91K | Oct 31 - Nov 02 | View |
| Oct 28, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -2.61K | $15.18 | -$39.58K | SELL | -34.70% | 4.91K | Oct 27 - Oct 28 | View |
| Oct 26, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -9.35K | $15.76 | -$147.36K | SELL | -65.58% | 4.91K | Oct 24 - Oct 26 | View |
| Oct 24, 2022 | Eric Easom | CHIEF EXECUTIVE OFFICER | -21.24K | $16.47 | -$349.91K | SELL | -81.24% | 4.91K | Oct 20 - Oct 21 | View |
| Aug 05, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | 1.91K | $7.51 | $14.33K | BUY | 0.05% | 3.77M | Aug 03 - Aug 04 | View |
| Jul 28, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | 23.22K | $7.78 | $180.67K | BUY | 0.62% | 3.77M | Jul 26 - Jul 27 | View |
| Jun 23, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | 302.00 | $7.99 | $2.41K | BUY | 0.01% | 3.75M | Jun 21 | View |
| Jun 15, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | 81.42K | $7.95 | $647.40K | BUY | 2.22% | 3.75M | Jun 13 - Jun 14 | View |
| Mar 31, 2022 | Robin Shane Readnour | DIRECTOR | 904.96K | $15.00 | $2.30M | BUY | ∞ | 487.59K | Mar 29 | View |
| Mar 31, 2022 | Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LP | 10% OWNER | 2.60M | $15.00 | $2.50M | BUY | ∞ | 2.21M | Mar 29 | View |
| Mar 31, 2022 | Kabeer Aziz | DIRECTOR | 2.60M | $15.00 | $2.50M | BUY | ∞ | 2.21M | Mar 29 | View |
| Mar 31, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | 10% OWNER | 3.67M | $15.00 | $25.00M | BUY | ∞ | 415.61K | Mar 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.